Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
Stock Snapshot
With a market cap of 19.8B, Illumina(ILMN) trades at $129.60. The stock has a price-to-earnings ratio of 29.47.
On 2025-12-18, Illumina(ILMN) stock traded between a low of $129.60 and a high of $129.60. Shares are currently priced at $129.60, which is 0.0% above the low and 0.0% below the high.
The Illumina(ILMN)'s current trading volume is 348, compared to an average daily volume of 1.64M.
During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $153.06 at its peak.
During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $153.06 at its peak.
ILMN News
Illumina (ILMN) shares have quietly turned a corner, with the stock up about 10% over the past month and nearly 28% in the past 3 months, drawing fresh attentio...
New insider activity at Illumina ( (ILMN) ) has taken place on December 16, 2025. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund...
Thermo Fisher Scientific TMO recently announced the expansion of its Gibco Bacto CD portfolio. The Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Fe...
Analyst ratings
43%
of 23 ratingsMore ILMN News
JPMorgan analyst Casey Woodring raised the firm’s price target on Illumina (ILMN) to $130 from $105 and keeps a Neutral rating on the shares. The firm updated m...
Illumina and MyOme recently announced a collaboration and Illumina investment to support MyOme’s Proactive Health Trial, which will test whether combining whole...